# Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head

> **NCT05637567** · PHASE2 · NOT_YET_RECRUITING · sponsor: **German Cancer Research Center** · enrollment: 170 (estimated)

## Conditions studied

- Pancreatic Cancer Resectable

## Interventions

- **DRUG:** Acetylsalicylic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05637567
- **Lead sponsor:** German Cancer Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04
- **Primary completion:** 2028-09
- **Final completion:** 2029-03
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05637567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05637567, "Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05637567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*